The cell type-specific effect of TAp73 isoforms on the cell cycle and apoptosis

Cellular and Molecular Biology Letters

Volumn 13, Issue 3, 2008, Pages 404-420

  Holcakova, Jitka ^a   Ceskova, Pavla ^a   Hrstka, Roman ^a   Muller, Petr ^a   Dubska, Lenka ^a   Coates, Philip J ^b   Palecek, Emil ^c   Vojtesek, Borivoj ^a  

^a MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c INSTITUTE OF BIOPHYSICS   (Czech Republic)

Author keywords

Apoptosis; Cell cycle; DNA binding; p53; TAp73; Transactivation; TAp73

Indexed keywords

DNA; PROTEIN P53; PROTEIN P73;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CELL TYPE; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION;

EID: 56349155743     PISSN: 14258153     EISSN: 16891392     Source Type: Journal    
DOI: 10.2478/s11658-008-0011-z     Document Type: Article

References (28)

1. Murray-Zmijewski, F., Lane, D.P. and Bourdon, J.C. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ. 13 (2006) 962-972.
2. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J.C., Valent, A., Minty, A., Chalon, P., Lelias, J.M., Dumont, X., Ferrara, P., McKeon, F. and Caput, D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90 (1997) 809-819.
3. Melino, G., De Laurenzi, V. and Vousden, K.H. p73: Friend or foe in tumorigenesis. Nat. Rev. Cancer 2 (2002) 605-615.
4. Dominguez, G., Garcia, J.M., Pena, C., Silva, J., Garcia, V., Martinez, L., Maximiano, C., Gomez, M.E., Rivera, J.A., Garcia-Andrade, C. and Bonilla, F. DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1. J. Clin. Oncol. 24 (2006) 805-815.
5. Concin, N., Becker, K., Slade, N., Erster, S., Mueller-Holzner, E., Ulmer, H., Daxenbichler, G., Zeimet, A., Zeillinger, R., Marth, C. and Moll, U.M. Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo. Cancer Res. 64 (2004) 2449-2460.
6. Deyoung, M.P. and Ellisen, L.W. p63 and p73 in human cancer: defining the network. Oncogene 26 (2007) 5169-5183.
7. Coates, P.J. Regulating p73 isoforms in human tumours. J. Pathol. 210 (2006) 385-389.
8. Flores, E.R., Tsai, K.Y., Crowley, D., Sengupta, S., Yang, A., McKeon, F. and Jacks, T. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 416 (2002) 560-564.
9. Irwin, M.S., Kondo, K., Marin, M.C., Cheng, L.S., Hahn, W.C. and Kaelin, W.G., Jr. Chemosensitivity linked to p73 function. Cancer Cell 3 (2003) 403-410.
10. Rocco, J.W., Leong, C.O., Kuperwasser, N., DeYoung, M.P. and Ellisen, L.W. p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 9 (2006) 45-56.
11. Vojtesek, B., Bartek, J., Midgley, C.A. and Lane, D.P. An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J. Immunol. Methods 151 (1992) 237-244.
12. Chen, J., Marechal, V. and Levine, A.J. Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol. 13 (1993) 4107-4114.
13. Fredersdorf, S., Milne, A.W., Hall, P.A. and Lu, X. Characterization of a panel of novel anti-p21Waf1/Cip1 monoclonal antibodies and immunochemical analysis of p21Waf1/Cip1 expression in normal human tissues. Am. J. Pathol. 148 (1996) 825-835.
14. Masuda, H., Miller, C., Koeffler, H.P., Battifora, H. and Cline, M.J. Rearrangement of the p53 gene in human osteogenic sarcomas. Proc. Natl. Acad. Sci. U S A 84 (1987) 7716-7719.
15. Bodner, S.M., Minna, J.D., Jensen, S.M., D'Amico, D., Carbone, D., Mitsudomi, T., Fedorko, J., Buchhagen, D.L., Nau, M.M. and Gazdar, A.F. Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene 7 (1992) 743-749.
16. th edition, Cold Spring Harbor Laboratory Press, 1989, 16.66-16.67.
17. Thurfjell, N., Coates, P.J., Uusitalo, T., Mahani, D., Dabelsteen, E., Dahlqvist, A., Sjostrom, B., Roos, G. and Nylander, K. Complex p63 mRNA isoform expression patterns in squamous cell carcinoma of the head and neck. Int. J. Oncol. 25 (2004) 27-35.
18. Boldrup, L., Bourdon, J.C., Coates, P.J., Sjostrom, B. and Nylander, K. Expression of p53 isoforms in squamous cell carcinoma of the head and neck. Eur. J. Cancer 43 (2007) 617-623.
19. Lohr, K., Moritz, C., Contente, A. and Dobbelstein, M. p21/CDKN1A mediates negative regulation of transcription by p53. J. Biol. Chem. 278 (2003) 32507-32516.
20. Grob, T.J., Novak, U., Maisse, C., Barcaroli, D., Luthi, A.U., Pirnia, F., Hugli, B., Graber, H.U., De Laurenzi, V., Fey, M.F., Melino, G. and Tobler, A. Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell. Death. Differ. 8 (2001) 1213-1223.
21. Ueda, Y., Hijikata, M., Takagi, S., Chiba, T. and Shimotohno, K. Transcriptional activities of p73 splicing variants are regulated by intervariant association. Biochem. J. 356 (2001) 859-866.
22. Brazda, V., Muller, P., Brozkova, K. and Vojtesek, B. Restoring wild-type conformation and DNA-binding activity of mutant p53 is insufficient for restoration of transcriptional activity. Biochem. Biophys. Res. Commun 351 (2006) 499-506.
23. Bernassola, F., Salomoni, P., Oberst, A., Di Como, C.J., Pagano, M., Melino, G. and Pandolfi, P.P. Ubiquitin-dependent degradation of p73 is inhibited by PML. J. Exp. Med. 199 (2004) 1545-1557.
24. Murphy, M., Ahn, J., Walker, K.K., Hoffman, W.H., Evans, R.M., Levine, A.J. and George, D.L. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes. Dev. 13 (1999) 2490-2501.
25. Lanza, M., Marinari, B., Papoutsaki, M., Giustizieri, M.L., D'Alessandra, Y., Chimenti, S., Guerrini, L. and Costanzo, A. Cross-talks in the p53 family: deltaNp63 is an anti-apoptotic target for deltaNp73alpha and p53 gain-of-function mutants. Cell Cycle 5 (2006) 1996-2004.
26. Terrasson, J., Allart, S., Martin, H., Lule, J., Haddada, H., Caput, D. and Davrinche, C. p73-dependent apoptosis through death receptor: impairment by human cytomegalovirus infection. Cancer Res. 65 (2005) 2787-2794.
27. Glasgow, J.N., Qiu, J., Rassin, D., Grafe, M., Wood, T. and Perez-Pol, J.R. Transcriptional regulation of the BCL-X gene by NF-kappaB is an element of hypoxic responses in the rat brain. Neurochem. Res. 26 (2001) 647-659.
28. Reed, J.C. Apoptosis-targeted therapies for cancer. Cancer Cell 3 (2003) 17-22.